Kyowa Kirin Co., Ltd. (FRA:KY4)

Germany · Delayed Price · Currency is EUR

15.00

+0.40 (2.74%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		495.56B	442.23B	398.37B	352.25B	318.35B
Pharmaceuticals Growth		12.06%	11.01%	13.09%	10.65%	4.10%
Total		495.56B	442.23B	398.37B	352.25B	318.35B
Total Growth		12.06%	11.01%	13.09%	10.65%	4.10%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan		141.17B	153.46B	154.64B	161.99B	166.64B
Japan Growth		-8.01%	-0.76%	-4.54%	-2.79%	-10.50%
Others		1.26B	972.00M	210.00M	217.00M	156.00M
Others Growth		29.94%	362.86%	-3.23%	39.10%	7.59%
Americas		-	-	-	-	72.18B
Americas Growth		-	-	-	-	45.23%
Europe		80.25B	65.75B	62.25B	53.36B	48.53B
Europe Growth		22.06%	5.61%	16.66%	9.95%	14.92%
Asia		52.47B	44.76B	37.37B	34.52B	30.85B
Asia Growth		17.22%	19.78%	8.26%	11.90%	11.90%
Americas (Except United States)		5.54B	5.05B	4.05B	2.84B	-
Americas (Except United States) Growth		9.68%	24.70%	42.96%	-	-
United States		214.87B	172.24B	139.85B	99.33B	-
United States Growth		24.75%	23.16%	40.80%	-	-
Total		495.56B	442.23B	398.37B	352.25B	318.35B
Total Growth		12.06%	11.01%	13.09%	10.65%	4.10%

Source: S&P Global Market Intelligence.